主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
EWTX
#1385
Edgewise Therapeutics, Inc. Common Stock
30.440
0
+2.42%
版块:
基础:
利润货币:
日范围
年范围
日变化
+2.42%
每月变动
+3.82%
6个月变化
+99.87%
年变化
+99.87%
前一天收盘价
29.720
0
Open
30.435
0
Bid
Ask
Low
30.435
0
High
30.440
0
交易量
140
市场
股票
医疗保健
EWTX
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
49.51 M
63.26 M
93.11 M
95.21 M
107.27 M
—
Valuation ratios
Enterprise value
740.98 M
534.08 M
938.12 M
2.5 B
2.6 B
7.87 B
Price to earnings ratio
-13.4
-6.98
-7.01
-18.41
-15.22
-48.3
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
17.11
8.95
7.62
22.63
17.76
57.56
Price to book ratio
2.09
1.36
2.2
5.37
4.89
7.42
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.15
-0.18
-0.29
-0.27
0.3
-0.13
Return on equity %
-0.16
-0.2
-0.31
-0.29
0.32
-0.13
Return on invested capital %
-65.99
-96.33
-158.55
-187.92
168.29
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
26.97
21.53
19.5
19.93
19.85
96.22
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.89
-0.98
-1.44
-1.18
1.4
-0.69
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.41
0.41
1.35
0.45
0.59
2
Net current asset value per share
7.56
6.66
5.13
5.15
5.28
21.6
Tangible book value per share
7.31
6.47
5
4.97
5.07
20.96
Working capital per share
7.28
6.35
4.87
4.89
5.01
20.69
Book value per share
7.31
6.47
5
4.97
5.07
20.96
新闻
Evercore ISI上调Edgewise Therapeutics目标价,基于HCM数据
Evercore ISI raises Edgewise Therapeutics price target on HCM data
Raymond James重申Edgewise Therapeutics股票强力买入评级
Raymond James reiterates Strong Buy on Edgewise Therapeutics stock
Stifel因试验数据时间表上调Edgewise Therapeutics目标价
Stifel raises Edgewise Therapeutics stock price target on trial data timeline
Edgewise Therapeutics stock hits 52-week high at $31.39
Edgewise Therapeutics即将公布财报,研发管线取得进展
Edgewise Therapeutics earnings on deck as pipeline advances
Edgewise Therapeutics股价创52周新高,达30.26美元
Edgewise Therapeutics stock hits 52-week high at $30.26
Piper Sandler重申Edgewise Therapeutics股票"增持"评级